Dalfampridine
Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies (14) ].
United States
$167
per month
India
$16
per month
You save
−90%save $150/mo · 90% cheaper
116.9K US scripts/yr$17.6M potential annual savings$19.5M US spend/yr
Drag to rotate · 3D structureC5H6N2
SMILES: C1=CN=CC=C1N
Compare the price
US price$167per month
India price$16per month
You save$15090% less
Based on 30 units per month. US $5.55 vs India $0.54 per unit.
Total over 1 periodSave $150$167 → $16
The bigger picture
Dalfampridine is filled about 116.9K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$19.5M
If sourced from India
$1.9M
Potential annual savings
$17.6M
−90%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.